Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intestinal gel

Active Ingredient:
levodopa , carbidopa monohydrate , entacapone
Company:  
Britannia Pharmaceuticals Limited See contact details
ATC code: 
N04BA03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Lecigon Best Practice Patient Aftercare

{healthcare_pro_orange} For Healthcare Professionals

This short guide provides advice to healthcare professionals on the management of patients with advanced Parkinson’s disease who have started LECIGON® therapy. LECIGON® is a gel containing levodopa/carbidopa / entacapone that is continually infused into the intestine by the pump Crono® LECIG pump (CE 0476) via a PEG-J tube. The Crono® LECIG pump manual contains instructions on how to use the pump.

{pdf_link}

Lecigon Critical Aspects of PEGJ Preparation Placement and Aftercare

{healthcare_pro_orange} For Healthcare Professionals

The information presented in these slides is provided as part of additional Risk Minimisation Program for LECIGON® targeted to minimise:

  • Gastrointestinal (GI) events
  • Device-related risks
  • Procedure-related risks associated with the Levodopa–carbidopa–entacapone intestinal gel system
{pdf_link}

Lecigon Patient Pocket Guide

This pocket guide provides a practical overview of the LECIGON® therapy and potential complications related to the medication and its delivery system.

{pdf_link}

Lecigon PegJ Aftercare Guideline

{healthcare_pro_orange} For Healthcare Professionals

This guide provides advice to healthcare professionals on how to minimise PEG-J tube related complications in patients receiving Lecigon® therapy. It should be used in conjunction with any local guidance and the Crono® LECIG pump manual.

{pdf_link}

Lecigon Safety PEG-J insertion and aftercare and pump operations

{healthcare_pro_orange} For Healthcare Professionals

The information presented in these slides is provided as part of additional Risk Minimisation Program for LECIGON® targeted to minimise:

  • Gastrointestinal (GI) events
  • Device-related risks
  • Procedure related risks

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Britannia Pharmaceuticals Limited
Company image
Address
200 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, UK
WWW
http://www.britannia-pharm.co.uk/
Telephone
+44 1189209500
Medical Information Direct Line
0808 196 8585
Medical Information e-mail
[email protected]